The Catalyst

Most Recent Posts

10.10.12 | By Preet Bilinski

Michael J. Fitzpatrick is executive director at NAMI, the National Alliance on Mental Illness.

10.09.12 | By Preet Bilinski

The stigma that surrounds mental illness remains a challenge. It can be difficult even for patients to accept and understand their diagnosis. So this week we join others in the mental health community participating in Mental Illness Awareness Week.

10.08.12

This morning, British scientist John Gurdon shared one of two Nobel Prizes awarded this year in physiology and medicine. Dr.

10.04.12 | By Kaelan Hollon

In this month's issue of Psychology Today, there was a good read about the psychological impact of having a rare disease, 'The Loneliest Fight', profiling four patients' experience with very differe

10.03.12

Medicare Today has released its 2012 beneficiary satisfaction survey results today and to put it simply, seniors love Medicare Part D.

10.03.12

Over a decade ago, when SARS (Severe Acute Respiratory Syndrome) was first detected in China, it took significant time to identify the virus and to understand how the disease spread among affected populations.

10.02.12

Scientific advances can be pretty thrilling.

10.01.12

Speaking as a father of three little ones, I can appreciate a parent's reluctance to medicate a child. Yes our pediatrician recommended the medicine, but is it really necessary? What about drug resistance over time?

10.01.12 | By Kaelan Hollon

Drugfree.org kicked off an amazing campaign to promote consumer awareness of safe medicine use and disposal - if you haven't seen their parent and teacher toolkits, you're missing out. And while their Project's kickoff may be over, our work to reduce prescription drug abuse continues on. In keeping that fire burning, I've asked PDMP Center of Excellence at Brandeis University Director John Eadie to guest blog post about what's going on in their neck of the woods.

10.01.12 | By John Castellani

In the parlance of corporate mergers, "Day 1" is a critical moment of transition. While not without challenges, Day 1 often brings a sense of excitement, promising growth platforms and long-term opportunities. When it comes to regulatory policy, this marks the biopharmaceutical research sector's Day 1.

09.27.12

Marv Shepherd, PhD, president of the Partnership for Safe Medicines, comments on Interchange 2012.

09.26.12

Yesterday morning, I was sitting with my daughter watching "Play with me Sesame" on the Sprout channel. Over the last couple of months, my daughter's love for this show has grown - she now dances to the songs and points to the television when she sees her favorite puppet Elmo.

09.26.12

I may be a creature of habit, but I still want options. Needless to say, I was pleased yesterday when I read about an increased number of available Medicare Part D plans with premiums below $20 (the national average is $30).

09.25.12 | By Kaelan Hollon

A large part of Drugfree.org's Medicine Abuse Project campaign talks through how to 'safeguard' medicines.

Pages